AU1628799A - Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites - Google Patents

Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites

Info

Publication number
AU1628799A
AU1628799A AU16287/99A AU1628799A AU1628799A AU 1628799 A AU1628799 A AU 1628799A AU 16287/99 A AU16287/99 A AU 16287/99A AU 1628799 A AU1628799 A AU 1628799A AU 1628799 A AU1628799 A AU 1628799A
Authority
AU
Australia
Prior art keywords
antimicrobial
targeting
biological
polar lipid
antineoplastic drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16287/99A
Other languages
English (en)
Inventor
Michael H. B Stowell
Milton B Yatvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health Science University filed Critical Oregon Health Science University
Publication of AU1628799A publication Critical patent/AU1628799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU16287/99A 1998-12-04 1998-12-04 Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites Abandoned AU1628799A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/025847 WO2000033883A1 (fr) 1998-12-04 1998-12-04 Conjugues lipides polaires covalents avec medicaments antimicrobiens et antineoplasiques destines a cibler des sites biologiques proteges

Publications (1)

Publication Number Publication Date
AU1628799A true AU1628799A (en) 2000-06-26

Family

ID=22268429

Family Applications (2)

Application Number Title Priority Date Filing Date
AU16287/99A Abandoned AU1628799A (en) 1998-12-04 1998-12-04 Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites
AU51141/99A Abandoned AU5114199A (en) 1998-12-04 1999-07-20 Conjugates of lipids and antimicrobial or antineoplastic drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU51141/99A Abandoned AU5114199A (en) 1998-12-04 1999-07-20 Conjugates of lipids and antimicrobial or antineoplastic drugs

Country Status (4)

Country Link
EP (1) EP1150718A1 (fr)
AU (2) AU1628799A (fr)
CA (1) CA2353832A1 (fr)
WO (1) WO2000033883A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015023524A1 (fr) * 2013-08-15 2015-02-19 Antivirus Therapeutics Procédés et compositions pour augmenter l'efficacité d'agents antiviraux
CN108735291A (zh) * 2018-05-21 2018-11-02 上海青研科技有限公司 基于内隐测试的毒品成瘾人员毒品渴求度测评方法及装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5827819A (en) * 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
JPH11514009A (ja) * 1996-07-23 1999-11-30 オレゴン ヘルス サイエンスィズ ユニヴァースティ 軟膏において用いるための、生物学的に活性の成分との共有結合極性脂質結合体

Also Published As

Publication number Publication date
WO2000033883A1 (fr) 2000-06-15
EP1150718A1 (fr) 2001-11-07
CA2353832A1 (fr) 2000-06-15
AU5114199A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
AU2639395A (en) Covalent microparticle-drug conjugates for biological targeting
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU2001270300A1 (en) Drug delivery formulations and targeting
AU4683099A (en) Targeted oligonucleotide conjugates
AU4570699A (en) Nucleosidic and non-nucleosidic folate conjugates
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
AU3999699A (en) Targeted liposomal drug delivery system
AU3053199A (en) Fused thiophene derivatives and drugs containing the same as the active ingredient
AU1833600A (en) Cannabimimetic lipid amides as useful medications
AU4548899A (en) Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU6593600A (en) Drugs inhibiting cell death
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU6460198A (en) Covalent conjugates of topoisomerase i and topoisomerase ii inhibitors
AU2001289635A1 (en) Polymeric conjugates of antitumor agents
AUPQ342599A0 (en) Conjugates and uses thereof
AU7737300A (en) Dna-cleaving rnase p rna
AU6940998A (en) Phospholipid drug derivatives
AU1628799A (en) Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites
AU2187699A (en) Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
AU2001264223A1 (en) Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU2002216864A1 (en) Conjugates of antibodies and anticancer drugs
AU7384401A (en) Active substance conjugates with intracellularly active ligands
IL123535A (en) Benzoxazinedione derivatives their conjugates with antibiotics and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase